Moody's Corporation (MCO)
NYSEFinancialsFinancial - Data & Stock ExchangesSnapshot 2026-10-29
$493.91+1.04%
Close 2026-10-30 · 1-day change
NYSEFinancialsFinancial - Data & Stock ExchangesSnapshot 2026-10-29
Research Workspace
Put MCO beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Financials is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue is growing steadily — about 9% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityManagement screens strong on capital allocation.
View ManagementExpectations look high — the market is pricing in about 44% growth a year, above the roughly 6% analysts expect, leaving little room for error.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskMoody’s case rests on achieving high-single-digit revenue growth in 2026, despite a recent slowdown. Revenue growth moved from 15% in Q2 to 1% in Q3, when adjusted EPS missed. MCO trades at 29× P/E versus a 12× peer median, with expectations exceeding our forecast. Jefferies flagged possible Q4 weakness in Ratings, while our model puts next-quarter miss probability near 21%. The 29× multiple must be earned despite that peer gap. Peer multiples imply a price about 44% below where it trades; our read remains intact. This read is provisional.
Trailing returns as of 2026-10-30. MCO is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 24 analysts currently covering MCO (as of Oct 2026).
Based on 8 Wall Street analysts offering 12-month price targets for MCO in the last 4 months.
Continue this research
Compare MCO with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| MCO Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 12 valuation methods, at three horizons. As of 2026-10-30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Financial Exchanges & Data — fair value, gap to price, and forward P/E.
Compare the value case
Put MCO next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Reported Q3 results miss forecasts, raising concern about growth and margin objectives.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
Current $493.91
The last 12 months of price, then the range of analyst 12-month targets from today’s $493.91.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
A reported Q3 double-miss and disappointing guidance challenge the growth and margin outlook.
Economic downturn in Botswana may impact revenue growth.
Advances: Achieve high-single-digit revenue growth for 2026
Upgrade supports revenue growth through improved credit ratings.
Weak earnings and high leverage may impact Moody's growth outlook.
Advances: Grow Moody's Analytics ARR in high-single-digit percent range
Upgrade supports growth in Moody's Analytics ARR.
Threatens: Achieve high-single-digit revenue growth for 2026
Weak paper market may hinder revenue growth objectives.
Advances: Achieve high-single-digit revenue growth for 2026
Strong quarterly performance supports revenue growth objective.